110. Blau syndrome Disease details / Clinical trials / Drug dev / DR info /
Clinical trials : 3 / Drugs : 3 - (DrugBank : 1) / Drug target genes : 4 - Drug target pathways : 39
Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)
Janus kinase inhibitor
Peking Union Medical College Hospital
2024 Phase 4 NCT06660329 China
OD-07656
Odyssey Therapeutics
2024 Phase 1 NCT06206811 Australia
Tofacitinib
Tongji Hospital
2017 - NCT06688838 China
Peking Union Medical College Hospital
2024 Phase 4 NCT06660329 China
OD-07656
Odyssey Therapeutics
2024 Phase 1 NCT06206811 Australia
Tofacitinib
Tongji Hospital
2017 - NCT06688838 China